-
Mashup Score: 33Stopping Aspirin Within 1 Month After Stenting for Ticagrelor Monotherapy in Acute Coronary Syndrome: The T-PASS Randomized Noninferiority Trial - 1 year(s) ago
Background: Stopping aspirin within 1 month after implantation of a drug-eluting stent (DES) for ticagrelor monotherapy has not been exclusively evaluated for patients with acute coronary syndrome (A
Source: www.ahajournals.orgCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 32Stopping Aspirin Within 1 Month After Stenting for Ticagrelor Monotherapy in Acute Coronary Syndrome: The T-PASS Randomized Noninferiority Trial - 1 year(s) ago
Background: Stopping aspirin within 1 month after implantation of a drug-eluting stent (DES) for ticagrelor monotherapy has not been exclusively evaluated for patients with acute coronary syndrome (A
Source: www.ahajournals.orgCategories: General Medicine News, CardiologistsTweet-
In T-PASS, aspirin discontinuation after a median of 16 days, followed by ticagrelor monotherapy, was superior for NACE compared with 12-mo DAPT in 2850 patients with ACS, with less bleeding. But KM curves opened late, which is a bit puzzling. #TCT2023 https://t.co/GAEGEpykmL
-
-
Mashup Score: 40Comparison of two self-expanding transcatheter heart valves for degenerated surgical bioprostheses: The AVENGER multicentre registry - 1 year(s) ago
The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)
Source: eurointervention.pcronline.comCategories: General Medicine News, CardiologistsTweet-
In the AVENGER registry, valve-in-valve TAVI using either the ACURATE neo/neo2 or EVOLUT R/PRO/PRO+ transcatheter heart valves showed similar procedural outcomes, but differences between the two devices emerged depending on the inner diameter. #TCT2023 https://t.co/FzIq7SuO3e https://t.co/NdeNdR5ruw
-
-
Mashup Score: 238
Original Article from The New England Journal of Medicine — Transcatheter Aortic-Valve Replacement in Low-Risk Patients at Five Years
Source: www.nejm.orgCategories: General Medicine News, CardiologistsTweet-
Five year results of PARTNER 3 trial now published in the NEJM. Conclusions are based on the primary composite outcomes, but two aspects will be a reason for discussion, I guess: crossing of death curves, and the higher rate of valve thrombosis with TAVI. https://t.co/TANbnin1QK https://t.co/BLhXTUvBUc
-
-
Mashup Score: 174Rotational atherectomy with cutting balloon to optimize stent expansion in calcified lesions: The ROTACUT randomized trial - 1 year(s) ago
The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)
Source: eurointervention.pcronline.comCategories: General Medicine News, CardiologistsTweet-
In the ROTACUT trial, lesion preparation with rotational atherectomy followed by cutting balloon angioplasty did not result in more optimal stent expansion compared with rotational atherectomy followed by non-compliant balloon post-dilatation. #TCT2023 https://t.co/b2itMCcSSn https://t.co/UzFMMt8uxg
-
-
Mashup Score: 1Anterior mitral leaflet modification with endoscopic scissors during Tendyne implantation - 1 year(s) ago
The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)
Source: eurointervention.pcronline.comCategories: Cardiologists, Latest HeadlinesTweet-
A woman with severe mitral regurgitation was not eligible to surgery or TEER. A Tendyne was considered, but it was at high risk of outflow tract obstruction. Laceration of the anterior mitral leaflet was obtained with a surgical endoscopic scissor (video). https://t.co/vJE46PUtSE https://t.co/YTOTJQ1rrO
-
-
Mashup Score: 6
The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)
Source: eurointervention.pcronline.comCategories: Cardiologists, Latest HeadlinesTweet-
In this IPD meta-analysis of 2,441 participants, ultrasound-guided transfemoral access significantly decreased major bleeding or vascular complications (odds ratio, 0.61; p=0.026) and was particularly beneficial in patients receiving a closure device. https://t.co/3fszEmnKVC https://t.co/ou9BAauZ2Q
-
-
Mashup Score: 3Lead Management in Patients Undergoing Percutaneous Tricuspid Valve Replacement or Repair: A “Heart Team” Approach - 1 year(s) ago
Abstract. Clinically significant tricuspid regurgitation (TR) has historically been managed with either medical therapy or surgical interventions. More recently
Source: academic.oup.comCategories: Cardiologists, Latest HeadlinesTweet-
Tricuspid regurgitation in patients with cardiac electronic devices may result from lead interactions. Decisions on tricuspid interventions and/or lead extraction in these patients must be careful and require a lead management specialist in the Heart Team. https://t.co/HM3peX7P4r https://t.co/cB2Bze5IMA
-
-
Mashup Score: 3
Atherosclerotic cardiovascular disease (ASCVD) is a prevalent chronic condition managed through pharmacotherapy targeting modifiable risk factors. How…
Source: www.sciencedirect.comCategories: Cardiologists, Latest HeadlinesTweet-
The polypill is a promising strategy for primary and secondary prevention of ASCVD, with the potential to reduce medication nonadherence and the risk of cardiovascular events. However, there are barriers to its utilization at multiple levels. Our review. https://t.co/TD0M224j3U https://t.co/waMxtodpbc
-
-
Mashup Score: 19Late-Breaking Science announced - 1 year(s) ago
See the impressive lineup of Late-Breaking Science on tap for presentation in Philadelphia.
Source: sessions.hub.heart.orgCategories: Cardiologists, Latest HeadlinesTweet-
Trials of this year's #AHA that intrigue me the most: 1) SELECT on semaglutide 2) ORBITA-2 on PCI 3) DAPA-MI on dapagliflozin 4) AZALEA on abelacimab 5) ARTESIA on apixaban 6) REMAIN-2 on recaticimab 7) A trial of lepodisiran 8) VERVE-101 on gene editing https://t.co/cP74P3GsyW
-
In T-PASS, aspirin discontinuation after a median of 16 days, followed by ticagrelor monotherapy, was superior for NACE compared with 12-mo DAPT in 2850 patients with ACS, with less bleeding. But KM curves opened late, which is a bit puzzling. #TCT2023 https://t.co/GAEGEpykmL